EMS management of acute stroke - Out-of-hospital treatment and stroke system development (resource document to NAEMSP position statement)

Prehospital Emergency Care

Volumn 11, Issue 3, 2007, Pages 318-325

  Millin, Michael G ^a   Gullett, Travis ^b   Daya, Mohamud R ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Tualatin Valley Fire and Rescue   (United States)

Author keywords

Emergency medical services; Stroke; Systems of care

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE DISEASE; BLOOD GLUCOSE MONITORING; CAUSE OF DEATH; DECISION MAKING; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTRAVENOUS ADMINISTRATION; MEDICAL SOCIETY; OXYGEN THERAPY; PARAMEDICAL PERSONNEL; REVIEW; STROKE; TREATMENT OUTCOME; UNITED STATES;

CEREBROVASCULAR ACCIDENT; EMERGENCY MEDICAL SERVICES; HUMANS; UNITED STATES;

EID: 34447125115     PISSN: 10903127     EISSN: 15450066     Source Type: Journal    
DOI: 10.1080/10903120701347885     Document Type: Review

References (92)

1. Heart Disease and Stroke Statistics-2005 Update. American Heart Association. Available at: http://www.americanheart.org/presenter. jhtml?identifier=1200026. Accessed Novemebr 7, 2005.
2. Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke. 2003;34(9):2109-12.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333(24):1581-87.
4. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283(9):1151-8.
5. Bravata DM, Kim N, Concato J, Krumholz HM, Brass LM. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med. 2002;162(17):1994- 2001.
6. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ. 2002;324(7339):723-9.
7. Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, Christianson TJ. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke. 2004;35(10):2418-24.
8. O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Ingall T, Louis TA. Report of the t-PA Review Committee. National Institute of Neurological Disorders and Stroke Available at: http://wwwnindsniggov/t-PA_review_committee. Accessed November 7, 2005.
9. O'Connor RE, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med. 1999;33(1):9-14.
10. Crocco T, Gullett T, Davis SM, Flores N, Sauerbeck L, Jauch E, Threlkeld B, Pio B, Ottaway M, Pancioli A, Chenier T. Feasibility of neuroprotective agent administration by prehospital personnel in an urban setting. Stroke. 2003;34(8):1918-22.
11. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke. 2004;35(5):e106-108.
12. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, O'Connor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36(7):1597-616.
13. Schwamm LH, Pancioli A, Acker JE 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, Magnis E, Adams RJ. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005;111(8):1078-91.
14. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33(4):373-8.
15. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke. 2000;31(1):71-6.
16. Kenning JA, Toutant SM, Saunders RL. Upright patient positioning in the management of intracranial hypertension. Surg Neurol. 1981;15(2):148-52.
17. Rosner MJ, Coley IB. Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg. 1986;65(5):636-41.
18. Woischneck D, Gaab MR. Intracranial pressure with head elevation. J Neurosurg. 1992;77(4):651-2.
19. Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke. 1984;15(3):492-6.
20. Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology. 1995;45(7):1286-90.
21. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke. 2002;33(2):497-501.
22. Wojner-Alexander AW, Garami Z, Chernyshev OY, Alexandrov AV. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology. 2005;64(8):1354-7.
23. Rowat AM, Dennis MS, Wardlaw JM. Hypoxaemia in acute stroke is frequent and worsens outcome. Cerebrovasc Dis. 2006;21(3):166-72.
24. Singhal AB, Wang X, Sumii T, Mori T, Lo EH. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab. 2002;22(7):861-8.
25. Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology. 2002;58(6):945-52.
26. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30(10):2033-7.
27. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36(4):797-802.
28. Bennett MH, Wasiak J, Schnabel A, Kranke P, French C. Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2005(3):CD004954.
29. Omae T, Ibayashi S, Kusuda K, Nakamura H, Yagi H, Fujishima M. Effects of high atmospheric pressure and oxygen on middle cerebral blood flow velocity in humans measured by transcranial Doppler. Stroke. 1998;29(1):94-7.
30. Watson NA, Beards SC, Altaf N, Kassner A, Jackson A. The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography. Eur J Anaesthesiol. 2000;17(3):152-9.
31. Langhorne P, Tong BL, Stott DJ. Association between physiological homeostasis and early recovery after stroke. Stroke. 2000;31(10):2518-9.
32. Evans A, Perez I, Harraf F, Melbourn A, Steadman J, Donaldson N, Kalra L. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet. 2001;358(9293):1586-92.
33. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important? Stroke. 1999;30(5):917-23.
34. Part 9: Adult Stroke. Circulation 2005;112(24 suppl):IV111-IV120.
35. Pace SA, Fuller FP, Dahlgren TJ. Paramedic decisions with placement of out-of-hospital intravenous lines. Am J Emerg Med. 1999;17(6):544-7.
36. Henderson RA, Thomson DP, Bahrs BA, Norman MP. Unnecessary intravenous access in the emergency setting. Prehosp Emerg Care. 1998;2(4):312-6.
37. Slovis CM, Herr EW, Londorf D, Little TD, Alexander BR, Guthmann RJ. Success rates for initiation of intravenous therapy en route by prehospital care providers. Am J Emerg Med. 1990;8(4):305-7.
38. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, Butman JA, Patronas N, Alger JR, Latour LL, Luby ML, Baird AE, Leary MC, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca JP, Davis S, Dunn B, Todd JW, Ezzeddine MA, Haymore J, Lynch JK, Davis L, Warach S. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004;292(15):1823-30.
39. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch JG, Heiland S, Wilde P, Jansen O, Rother J, Hacke W, Sartor K. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35(2):502-6.
40. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev. 2002(4):CD000103.
41. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1):136-40.
42. Bhardwaj A, Harukuni I, Murphy SJ, Alkayed NJ, Crain BJ, Koehler RC, Hurn PD, Traystman RJ. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000;31(7):1694-701.
43. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52(2):280-4.
44. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314(7090):1303-6.
45. Kelly J, Hunt BJ, Lewis RR, Swaminathan R, Moody A, Seed PT, Rudd A. Dehydration and venous thromboembolism after acute stroke. QJM. 2004;97(5):293-6.
46. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke. 2000;31(9):2043-8.
47. Laowattana S, Zeger SL, Lima JA, Goodman SN, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006;66(4):477-83; discussion 463.
48. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin. 1992;10(1):167-76.
49. Myers MG, Norris JW, Hachinski VC, Weingert ME, Sole MJ. Cardiac sequelae of acute stroke. Stroke. 1982;13(6):838-42.
50. Korpelainen JT, Sotaniemi KA, Makikallio A, Huikuri HV, Myllyla VV. Dynamic behavior of heart rate in ischemic stroke. Stroke. 1999;30(5):1008-13.
51. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36(12):2748-55.
52. Oppenheimer SM, Cechetto DF, Hachinski VC. Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death. Arch Neurol. 1990;47(5):513-9.
53. Lane RD, Wallace JD, Petrosky PP, Schwartz GE, Gradman AH. Supraventricular tachycardia in patients with right hemisphere strokes. Stroke. 1992;23(3):362-6.
54. Huff JS. Stroke mimics and chameleons. Emerg Med Clin North Am. 2002;20(3):583-95.
55. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59(5):669-74.
56. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke. 1986;17(5):865-71.
57. Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan AM. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30(1):34-9.
58. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006;13(2):174-80.
59. Walters MR, Weir CJ, Lees KR. A Randomised, Controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis. 2006;22(2-3):116-22.
60. Johnston K. Glucose Regulation in Acute Stroke Patient Trial. Stroke Trials Registry. Updated on 03/02/06. Available at: http://www.strokecenter.org/ trials. Accessed May 18, 2006.
61. Bruno A. Treatment of hyperglycemia in ischemic stroke. Stroke Trials Registry. Updated on 02/16/06. Available at: http://www.strokecenter.org/trials. Accessed May 18, 2006.
62. Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2003(2):CD000029.
63. Easton JD. What have we learned from recent antiplatelet trials? Neurology. 1998;51(3 suppl 3):S36-38.
64. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349(9065):1569-81.
65. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349(9066):1641-9.
66. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31(6):1240-9.
67. Schmulling S, Rudolf J, Strotmann-Tack T, Grond M, Schneweis S, Sobesky J, Thiel A, Heiss WD. Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke. Cerebrovasc Dis. 2003;16(3):183-90.
68. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280(22):1930-5.
69. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke. 2005;36(8):1801-7.
70. Spengos K, Tsivgoulis G, Zakopoulos N. Blood pressure management in acute stroke: a long-standing debate. Eur Neurol. 2006;55(3):123-35.
71. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43(1):18-24.
72. Bath P. High blood pressure as risk factor and prognostic predictor in acute ischaemic stroke: when and how to treat it? Cerebrovasc Dis. 2004;17 (suppl 1):51-7.
73. Broderick J, Brott T, Barsan W, Haley EC, Levy D, Marler J, Sheppard G, Blum C. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med. 1993;22(9):1438-43.
74. Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology. 2003;61(8):1047-51.
75. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35(2):520-6.
76. Vlcek M, Schillinger M, Lang W, Lalouschek W, Bur A, Hirschl MM. Association between course of blood pressure within the first 24 hours and functional recovery after acute ischemic stroke. Ann Emerg Med. 2003;42(5):619-26.
77. Hillis AE, Ulatowski JA, Barker PB, Torbey M, Ziai W, Beauchamp NJ, Oh S, Wityk RJ. A pilot randomized trial of induced blood pressure elevation: effectsonfunctionandfocal perfusion in acute and subacute stroke. Cerebrovasc Dis. 2003;16(3):236-46.
78. Chalela JA, Dunn B, Todd JW, Warach S. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology. 2005;64(11):1979.
79. Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36(4):916-23.
80. Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage:Astatement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30(4):905-15.
81. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283(23):3102-9.
82. Joint Commission's Certificate of Distinction for Primary Stroke Centers.: Joint Commission on Accreditation of Healthcare Organizations. Available at: http://www.jcaho.org/dscc/dsc/certification+information/ stroke_brochure.pdf. Accessed October 24, 2005.
83. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342(8868):395-8.
84. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke. 1991;22(8):1026-31.
85. Wood-Dauphinee S, Shapiro S, Bass E, Fletcher C, Georges P, Hensby V, Mendelsohn B. A randomized trial of team care following stroke. Stroke. 1984;15(5):864-72.
86. Sivenius J, Pyorala K, Heinonen OP, Salonen JT, Riekkinen P. The significance of intensity of rehabilitation of stroke-a controlled trial. Stroke. 1985;16(6):928-31.
87. Strand T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester PO. A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke. 1985;16(1):29-34.
88. Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005;36(7):1512-8.
89. Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology. 2003;61(6):792-6.
90. Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke. 1996;27(11):1937-43.
91. Primary Stroke Center Certification. Joint Commission on Acredidation of Healthcare Organizations. Available at: http://www.jcaho.org/dscc/psc/index.htm. Accessed October 24, 2005.
92. Disease-Specific Care Certification Program. Joint Commission on Accredidation of Healthcare Organizations. Available at: http://www.jcaho.org/ dscc/psc/guide.htm. Accessed October 24, 2005.